Who should not take Ipamorelin?
Documented caution flags for Ipamorelin include active malignancy and pregnancy / nursing. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for Ipamorelin is limited.
Documented caution flags for Ipamorelin
- Active malignancy
- Pregnancy / nursing
Reported side effects to weigh
- Head-rush at injection
- Mild hunger pulse 30 min post-dose
- Tingling in hands rarely
References
- Ipamorelin, the first selective GH secretagogue — Raun K et al., Eur J Endocrinol, 1998
- Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients — Beck DE et al., International Journal of Colorectal Disease, 2014
- Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications — Villegas Meza AD et al., JBJS Reviews, 2026
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Ipamorelin
Full Ipamorelin breakdownIpamorelin what it's used forIpamorelin side effectsIpamorelin how to take itIpamorelin mistakes to avoidIpamorelin half-lifeIpamorelin how long to workIpamorelin legal statusIpamorelin how it worksipamorelin vs cjc 1295mk 677 vs ipamorelinipamorelin vs tesamorelinhexarelin vs ipamorelinAsk the AI Coach
Last updated 2026-06-15.